TY - JOUR
T1 - Identification and quantification of anti-gp.Mur antibodies in human serum using an insect-cell-based system
AU - Lamis, Robert John S.
AU - Chiueh, Tsong Shi
AU - Tsai, Chih Hsuan
AU - Lo, Huei Ru
AU - Wei, Sung Chan
AU - Chao, Yu Chan
N1 - Funding Information:
Funding: This research was funded by grants MOST 109-2327-B-016-004, MOST 109-2927-I-001-511, MOST 109-2321-B-033-001, MOST 109-2313-B-001-017, and MOST 110-2923-B-001-001 from the Ministry of Science and Technology, and it was also funded by grants under the 2019 NBRP Translational Research Project, Taiwan, ROC.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
PY - 2021/6
Y1 - 2021/6
N2 - Gp.Mur is a clinically relevant antigen of the MNS blood group system that is highly prevalent in several Asian populations. Its corresponding antibody, anti-Gp.Mur, has been implicated in hemolytic transfusion reactions and hemolytic disease of the fetus and newborn. Currently, identifying and confirming anti-Gp.Mur antibody presence in sera via agglutination of a panel of red blood cells (RBCs) is inefficient and difficult to quantify. Using a baculovirus expression system to express Gp.Mur antigen on insect cell surfaces, we have developed a quantitative cell-based system to confirm the presence of anti-Gp.Mur antibody in human serum. We obtained 10 serum samples preidentified as having anti-Gp.Mur antibody and another 4 samples containing noncorresponding antibodies from hospital patients. Insect cells displaying Gp.Mur antigen successfully adsorbed anti-Gp.Mur antibody in the sera and inhibited the RBC agglutination mediated by this antibody. By varying the concentration of Gp.Mur-displaying cells, we could grade levels of RBC agglutination by anti-Gp.Mur antibody. Densitometric analysis further enabled quantitative determinations of hemagglutination inhibition by Gp.Mur-displaying cells. We believe that this cell-based hemagglutination inhibition system greatly improves or supplements existing technology and is a convenient means for accurately identifying and quantifying anti-Gp.Mur antibody.
AB - Gp.Mur is a clinically relevant antigen of the MNS blood group system that is highly prevalent in several Asian populations. Its corresponding antibody, anti-Gp.Mur, has been implicated in hemolytic transfusion reactions and hemolytic disease of the fetus and newborn. Currently, identifying and confirming anti-Gp.Mur antibody presence in sera via agglutination of a panel of red blood cells (RBCs) is inefficient and difficult to quantify. Using a baculovirus expression system to express Gp.Mur antigen on insect cell surfaces, we have developed a quantitative cell-based system to confirm the presence of anti-Gp.Mur antibody in human serum. We obtained 10 serum samples preidentified as having anti-Gp.Mur antibody and another 4 samples containing noncorresponding antibodies from hospital patients. Insect cells displaying Gp.Mur antigen successfully adsorbed anti-Gp.Mur antibody in the sera and inhibited the RBC agglutination mediated by this antibody. By varying the concentration of Gp.Mur-displaying cells, we could grade levels of RBC agglutination by anti-Gp.Mur antibody. Densitometric analysis further enabled quantitative determinations of hemagglutination inhibition by Gp.Mur-displaying cells. We believe that this cell-based hemagglutination inhibition system greatly improves or supplements existing technology and is a convenient means for accurately identifying and quantifying anti-Gp.Mur antibody.
UR - http://www.scopus.com/inward/record.url?scp=85107795416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107795416&partnerID=8YFLogxK
U2 - 10.3390/diagnostics11060966
DO - 10.3390/diagnostics11060966
M3 - Article
AN - SCOPUS:85107795416
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 6
M1 - 966
ER -